176 related articles for article (PubMed ID: 26928373)
1. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.
Tang KT; Hung WT; Chen YH; Lin CH; Chen DY
Sci Rep; 2016 Mar; 6():22387. PubMed ID: 26928373
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C.
Tang KT; Chen YH; Lin CH; Chen DY
Sci Rep; 2016 Sep; 6():33104. PubMed ID: 27609026
[TBL] [Abstract][Full Text] [Related]
3. Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: Real-world data from a nationwide cohort study in Taiwan.
Tang KT; Chen YM; Chang SN; Lin CH; Chen DY
J Am Acad Dermatol; 2018 Oct; 79(4):652-658. PubMed ID: 29753054
[TBL] [Abstract][Full Text] [Related]
4. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
[TBL] [Abstract][Full Text] [Related]
6. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
[TBL] [Abstract][Full Text] [Related]
7. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
Feuchtenberger M; Kraus L; Nigg A; Schulze-Koops H; Schäfer A
Rheumatol Int; 2021 Jun; 41(6):1079-1087. PubMed ID: 33608744
[TBL] [Abstract][Full Text] [Related]
11. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
Minocha A; Dean HA; Pittsley RA
Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis.
Moreno-Otero R; García-Buey L; García-Sanchez A; Trapero-Marugán M
Curr Drug Saf; 2011 Jul; 6(3):197-200. PubMed ID: 22122395
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
McLean-Tooke A; Aldridge C; Waugh S; Spickett GP; Kay L
Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
[TBL] [Abstract][Full Text] [Related]
17. [Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice].
La Montagna G; Tirri R; Vitello R; Malesci D; Buono R; Mennillo G; Valentini G
Reumatismo; 2006; 58(4):261-7. PubMed ID: 17216014
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.
Mor A; Bingham CO; Kishimoto M; Izmirly PM; Greenberg JD; Reddy S; Rosenthal PB
Ann Rheum Dis; 2008 Apr; 67(4):462-5. PubMed ID: 17711866
[TBL] [Abstract][Full Text] [Related]
19. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
Sante; 2001; 11(3):195-200. PubMed ID: 11641084
[TBL] [Abstract][Full Text] [Related]
20. Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index.
Avouac J; Degrave R; Vergneault H; Combier A; Wanono S; Boisson M; Frantz C; Allanore Y
Clin Exp Rheumatol; 2022 Jan; 40(1):150-157. PubMed ID: 33938795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
